M Skinner

4.2k total citations
65 papers, 3.2k citations indexed

About

M Skinner is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, M Skinner has authored 65 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 11 papers in Oncology and 10 papers in Genetics. Recurrent topics in M Skinner's work include Amyloidosis: Diagnosis, Treatment, Outcomes (50 papers), Alzheimer's disease research and treatments (8 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers). M Skinner is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (50 papers), Alzheimer's disease research and treatments (8 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers). M Skinner collaborates with scholars based in United States, United Kingdom and Sweden. M Skinner's co-authors include Alan S. Cohen, T Shirahama, David C. Seldin, Vaishali Sanchorawala, Rodney H. Falk, Lawreen H. Connors, Simon W Dubrey, Kyle T. Finn, Daniel G. Wright and John L. Berk and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

M Skinner

64 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Skinner United States 31 2.7k 673 586 518 457 65 3.2k
Gibbons G. Cornwell United States 22 1.7k 0.7× 577 0.9× 418 0.7× 351 0.7× 114 0.2× 52 2.3k
Yoshihito Yawata Japan 22 795 0.3× 760 1.1× 380 0.6× 157 0.3× 67 0.1× 113 2.3k
Jonathan H. Axelrod Israel 25 919 0.3× 170 0.3× 416 0.7× 241 0.5× 237 0.5× 45 2.2k
Barbara Kluve‐Beckerman United States 23 1.5k 0.6× 426 0.6× 334 0.6× 202 0.4× 116 0.3× 56 1.8k
Isao Shirato Japan 29 833 0.3× 154 0.2× 152 0.3× 1.6k 3.1× 228 0.5× 101 2.8k
Ramin Radpour Switzerland 30 1.3k 0.5× 105 0.2× 595 1.0× 166 0.3× 147 0.3× 72 2.7k
Françoise Porteu France 26 1.3k 0.5× 211 0.3× 533 0.9× 45 0.1× 213 0.5× 51 2.6k
Randolph A. Hennigar United States 23 1.2k 0.5× 113 0.2× 199 0.3× 555 1.1× 115 0.3× 49 2.5k
Linda K. Myers United States 31 651 0.2× 145 0.2× 430 0.7× 75 0.1× 204 0.4× 102 3.2k
Chin‐Yuan Tzen Taiwan 25 906 0.3× 166 0.2× 649 1.1× 267 0.5× 253 0.6× 82 2.4k

Countries citing papers authored by M Skinner

Since Specialization
Citations

This map shows the geographic impact of M Skinner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Skinner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Skinner more than expected).

Fields of papers citing papers by M Skinner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Skinner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Skinner. The network helps show where M Skinner may publish in the future.

Co-authorship network of co-authors of M Skinner

This figure shows the co-authorship network connecting the top 25 collaborators of M Skinner. A scholar is included among the top collaborators of M Skinner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Skinner. M Skinner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Comenzo, Raymond L., Donna Reece, Giovanni Palladini, et al.. (2012). Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis. Leukemia. 26(11). 2317–2325. 267 indexed citations
2.
Berk, John L., P. James B. Dyck, Laura Obici, et al.. (2011). The diflunisal trial: update on study drug tolerance and disease progression. Amyloid. 18(sup1). 196–197. 26 indexed citations
3.
Girnius, Saulius, Laura M. Dember, Gheorghe Doros, & M Skinner. (2011). The changing face of AA amyloidosis: a single center experience. Amyloid. 18(sup1). 226–228. 23 indexed citations
4.
Meier-Ewert, Hans K., Vaishali Sanchorawala, John L. Berk, et al.. (2011). Regression of cardiac wall thickness following chemotherapy and stem cell transplantation for light chain (AL) amyloidosis. Amyloid. 18(sup1). 130–131. 26 indexed citations
5.
Sanchorawala, Vaishali, DG Wright, Michael Rosenzweig, et al.. (2006). A phase II trial of lenalidomide for patients with AL amyloidosis. Journal of Clinical Oncology. 24(18_suppl). 7524–7524. 2 indexed citations
6.
Sanchorawala, Vaishali, Elizabeth Blanchard, David C. Seldin, et al.. (2006). AL amyloidosis associated with B‐cell lymphoproliferative disorders: Frequency and treatment outcomes. American Journal of Hematology. 81(9). 692–695. 43 indexed citations
7.
Dember, Laura M., Tatiana Prokaeva, Daniel G. Wright, et al.. (2006). Clinical and molecular characteristics of patients with non-amyloid light chain deposition disorders, and outcome following treatment with high-dose melphalan and autologous stem cell transplantation. Bone Marrow Transplantation. 38(5). 339–343. 43 indexed citations
8.
Sanchorawala, Vaishali, Daniel G. Wright, David C. Seldin, et al.. (2003). High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: results of a prospective randomized trial. Bone Marrow Transplantation. 33(4). 381–388. 96 indexed citations
9.
Akpek, Görgün, Georg Lenz, Siow Ming Lee, et al.. (2001). Immunologic recovery after autologous blood stem cell transplantation in patients with AL-amyloidosis. Bone Marrow Transplantation. 28(12). 1105–1109. 10 indexed citations
10.
Wally, Jeremy, Tracy Zhang, Thomas Ericsson, et al.. (1999). Identification of a novel substitution in the constant region of a gene coding for an amyloidogenic κ1 light chain. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1454(1). 49–56. 22 indexed citations
11.
LeBlanc, M. M., Jeremy Wally, Safa Karandish, et al.. (1998). Mobilized CD34+ cells selected as autografts in patients with primary light‐chain amyloidosis: rationale and application. Transfusion. 38(1). 60–69. 35 indexed citations
12.
13.
Skinner, M & Robert A. Kyle. (1992). Protein AA/SAA. Journal of Internal Medicine. 232(6). 513–514. 17 indexed citations
14.
Jones, Lisa, et al.. (1992). Familial amyloidotic polyneuropathy: a new transthyretin position 30 mutation (alanine for valine) in a family of German descent. Clinical Genetics. 41(2). 70–73. 31 indexed citations
15.
Alves, Isabel L., Maria Rosário Almeida, James Skare, et al.. (1992). Amyloidogenic and non‐amyloidogenic transthyretin Asn 90 variants. Clinical Genetics. 42(1). 27–30. 8 indexed citations
16.
Skinner, M, T. Okuyama, F Gejyo, et al.. (1990). Glycosaminoglycans of the hemodialysis-associated carpal synovial amyloid and of amyloid-rich tissues and fibrils of heart, liver, and spleen. Clinical Chemistry. 36(1). 88–91. 56 indexed citations
17.
Connors, Lawreen H., Morie A. Gertz, M Skinner, & Alan S. Cohen. (1984). Nephelometric measurement of human serum prealbumin and correlation with acute-phase proteins CRP and SAA: results in familial amyloid polyneuropathy.. PubMed. 104(4). 538–45. 20 indexed citations
18.
Skinner, M, T Shirahama, M D Benson, & Alan S. Cohen. (1977). Murine amyloid protein AA in casein-induced experimental amyloidosis.. PubMed. 36(4). 420–7. 86 indexed citations
19.
Scheinberg, Morton, et al.. (1977). Kinetics of serum amyloid protein A in casein-induced murine amyloidosis.. Journal of Clinical Investigation. 59(3). 412–417. 68 indexed citations
20.
Paul, Stéphane, et al.. (1972). Specific Immunofluorescence Test for Detection of Herpesvirus Antigen in Cells of the Lucke Renal Adenocarcinoma. Experimental Biology and Medicine. 139(3). 944–948. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gibbons G. Cornwell Breakdown of academic impact, for papers by Yoshihito Yawata Breakdown of academic impact, for papers by Jonathan H. Axelrod Breakdown of academic impact, for papers by Barbara Kluve‐Beckerman Breakdown of academic impact, for papers by Isao Shirato Breakdown of academic impact, for papers by Ramin Radpour Breakdown of academic impact, for papers by Françoise Porteu Breakdown of academic impact, for papers by Randolph A. Hennigar Breakdown of academic impact, for papers by Linda K. Myers Breakdown of academic impact, for papers by Chin‐Yuan Tzen
Rankless by CCL
2026